{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P68036",
      "entity_text" : "UBE2L3",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The amount of UBE2L3 exerts rate limiting control over LUBAC mediated NF-kappaB activation, and together UBE2L3 and LUBAC play an important role in late-phase NF-kappaB activation in response to TNF.",
  "reading_complete" : "2020-08-08T12:01:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:59:36Z",
  "trigger" : "mediated",
  "evidence" : [ "UBE2L3 exerts rate-limiting control over LUBAC-mediated NF-kappaB" ],
  "pmc_id" : "4320258",
  "score" : 0
}